Tag Archives: small molecules

Hot Life Science Investor Mandate 3: Single Family Office Looking to Catalyze Larger Funding Rounds

3 Jul

A Family Office based in the Eastern United States is looking to make equity investments into early stage companies in the life science space that can be used to catalyze larger rounds from other institutional investors. The firm’s typical allocation size is between $200,000-$500,000. The firm is currently looking for companies around the US. The firm is looking to make approximately 4 investments over the next 6-9 months.

The firm is currently looking for companies developing therapeutics and is open to both small molecules and biologics. The firm is generally open to all indications within these areas including orphan indications. The firm is willing to invest in both pre-clinical and clinical stage companies with a preference for those with some in-human data.

The firm is looking for privately held companies with experienced management teams. The firm’s main mission is to help companies catalyze larger rounds by helping attract other more large scale investors. The firm looks to take a board seat on a case by case basis.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

%d bloggers like this: